125 related articles for article (PubMed ID: 35225194)
1. Differential heterologous neutralisation profile against strains within DENV-3 genotype II.
Tan KK; Abubakar S
Epidemiol Infect; 2021 Dec; 150():e33. PubMed ID: 35225194
[TBL] [Abstract][Full Text] [Related]
2. Autochthonous spread of DENV-3 genotype III in Malaysia mitigated by pre-existing homotypic and heterotypic immunity.
Tan KK; Nellis S; Zulkifle NI; Sulaiman S; AbuBakar S
Epidemiol Infect; 2018 Oct; 146(13):1635-1641. PubMed ID: 29860959
[TBL] [Abstract][Full Text] [Related]
3. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus).
Azami NAM; Moi ML; Ami Y; Suzaki Y; Lim CK; Taniguchi S; Saijo M; Takasaki T; Kurane I
Virol J; 2018 Mar; 15(1):51. PubMed ID: 29587780
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.
Messer WB; Yount B; Hacker KE; Donaldson EF; Huynh JP; de Silva AM; Baric RS
PLoS Negl Trop Dis; 2012; 6(2):e1486. PubMed ID: 22389731
[TBL] [Abstract][Full Text] [Related]
6. Dengue virus type 1 clade replacement in recurring homotypic outbreaks.
Teoh BT; Sam SS; Tan KK; Johari J; Shu MH; Danlami MB; Abd-Jamil J; MatRahim N; Mahadi NM; AbuBakar S
BMC Evol Biol; 2013 Sep; 13():213. PubMed ID: 24073945
[TBL] [Abstract][Full Text] [Related]
7. Antibody neutralization and viral virulence in recurring dengue virus type 2 outbreaks.
Wong SS; Abd-Jamil J; Abubakar S
Viral Immunol; 2007 Sep; 20(3):359-68. PubMed ID: 17931106
[TBL] [Abstract][Full Text] [Related]
8. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients.
Yamanaka A; Moi ML; Takasaki T; Kurane I; Konishi E
J Gen Virol; 2017 Feb; 98(2):166-172. PubMed ID: 27911254
[TBL] [Abstract][Full Text] [Related]
10. Disruption of predicted dengue virus type 3 major outbreak cycle coincided with switching of the dominant circulating virus genotype.
Tan KK; Zulkifle NI; Abd-Jamil J; Sulaiman S; Yaacob CN; Azizan NS; Che Mat Seri NAA; Samsudin NI; Mahfodz NH; AbuBakar S
Infect Genet Evol; 2017 Oct; 54():271-275. PubMed ID: 28698156
[TBL] [Abstract][Full Text] [Related]
11. Genotype-specific neutralization and protection by antibodies against dengue virus type 3.
Brien JD; Austin SK; Sukupolvi-Petty S; O'Brien KM; Johnson S; Fremont DH; Diamond MS
J Virol; 2010 Oct; 84(20):10630-43. PubMed ID: 20702644
[TBL] [Abstract][Full Text] [Related]
12. Sera of patients with systemic lupus erythematosus cross-neutralizes dengue viruses.
Zainal N; Tan KK; Johari J; Hussein H; Wan Musa WR; Hassan J; Lin YS; AbuBakar S
Microbiol Immunol; 2018 Oct; 62(10):659-672. PubMed ID: 30259549
[TBL] [Abstract][Full Text] [Related]
13. Increasing Clinical Severity during a Dengue Virus Type 3 Cuban Epidemic: Deep Sequencing of Evolving Viral Populations.
Rodriguez-Roche R; Blanc H; Bordería AV; Díaz G; Henningsson R; Gonzalez D; Santana E; Alvarez M; Castro O; Fontes M; Vignuzzi M; Guzman MG
J Virol; 2016 May; 90(9):4320-4333. PubMed ID: 26889031
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection.
Auerswald H; Kann S; Klepsch L; Hülsemann J; Rudnik I; Schreiber S; Buchy P; Schreiber M
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696387
[TBL] [Abstract][Full Text] [Related]
15. Serologic and Virologic Studies of an Imported Dengue Case Occurring in 2014 in Okinawa, Japan.
Saito M; Tamayose M; Miyagi K; Takaragawa H; Tateyama M; Tadano M; Fujita J
Jpn J Infect Dis; 2016; 69(1):60-5. PubMed ID: 26073738
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibody response variation against dengue 3 strains.
Alvarez M; Pavon-Oro A; Rodriguez-Roche R; Bernardo L; Morier L; Sanchez L; Alvarez AM; Guzmán MG
J Med Virol; 2008 Oct; 80(10):1783-9. PubMed ID: 18712848
[TBL] [Abstract][Full Text] [Related]
17. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
Uno N; Ross TM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
[TBL] [Abstract][Full Text] [Related]
18. Emergence of dengue virus type 1 and type 3 as dominant serotypes during 2017 in Pune and Nashik regions of Maharashtra, Western India.
Patil JA; Alagarasu K; Kakade MB; More AM; Gadekar KA; Jadhav SM; Parashar D; Shah PS
Infect Genet Evol; 2018 Dec; 66():272-283. PubMed ID: 30366083
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and genotype shift of dengue virus strains between 2001 and 2014 in Guangzhou.
Jiang LY; Jing QL; Liu Y; Cao YM; Su WZ; Biao D; Yang ZC
Epidemiol Infect; 2017 Mar; 145(4):760-765. PubMed ID: 27919298
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
